SGLT2 INHIBITORS

Clinical trials for SGLT2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Flozins under the microscope: can they protect heart and kidneys in High-Risk patients?

Knowledge-focused Recruiting now

This observational study follows 200 adults with chronic kidney disease and a type of heart failure (HFpEF), some taking SGLT2 inhibitors (flozins) and some not. Researchers will measure arterial stiffness, heart function, and kidney decline over time to see if flozins are linked…

Matched conditions: SGLT2 INHIBITORS

Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:58 UTC

SGLT2 INHIBITORS

Get alerted when new SGLT2 INHIBITORS trials appear

Flozins under the microscope: can they protect heart and kidneys in High-Risk patients?